CVS Health Corp will pay $22 million to settle a three-year federal investigation into whether two of the company’s pharmacies in central Florida sold oxycodone that was not prescribed for legitimate medical purposes.
The U.S. Drug Enforcement Agency (DEA) announced the deal Wednesday, officially bringing an end to the probe. According to a news release posted on the DEA’s website, Florida is the nation’s “epicenter” for the illegal distribution of prescription drugs. Prescription drug addicts were traveling to Florida to find doctors who would write prescriptions for oxycodone, a powerful and potentially addictive painkiller, as well as pharmacies that would fill the prescriptions, despite signs that they were illegitimate prescriptions. The investigation led to the DEA’s execution of administrative inspection warrants at the Sanford, Florida pharmacies. The government revoked the pharmacies’ licenses in June 2012. More CVS Health Acknowledges Two of its Florida Pharmacies Sold Oxycodone for Illegitimate Purposes, Agrees to Pay Government $22 Million